ZyVersa Therapeutics Inc. (NASDAQ:ZVSA) currently has a daily average trading volume of 1.50M but it saw 1463516 shares traded on Thursday. With a market cap of 7.29M USD, stock’s current market price of $0.41 came falling about -5.88 while comparing to the previous closing price of $0.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.00 and as low as $0.37. In the recent trading on the day, stock has struck highest price mark of $0.4499 while lowest mark touched by it was $0.41.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Taking a look at 20-day trading activity of ZyVersa Therapeutics Inc. (ZVSA) gives us an average price of $0.4765, while its current price level is -98.36% below from 52-week high level whereas it is 11.44% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2252 while that of 200 days or SMA-200 reads an average of $5.4577. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.19% during that period while stretching the period over a month that increases to 15.22%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.66 which implies that the stock is in oversold territory.
Over the week, ZVSA’s stock price is moving 10.93% up while it is -17.67% when we observe its performance for the past one month. Year-to-date it is -73.89% down and over the past year.
Currently, ZyVersa Therapeutics Inc.’s total number of outstanding shares is 9.13M with 54.99% of that held by the insiders while 6.08% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -56.30%. Stock has a price to book (P/B) ratio of 0.04. Its return on asset (ROA) is -40.30% on average.
A filing at the U.S. Securities and Exchange Commission revealed that RiverNorth Opportunities Fund Inc came shrinking its share ownership by -25.00% in the ZyVersa Therapeutics Inc. (ZVSA) decreasing its stake to 0.24% with control over 16157.0 shares in the company. In the most recent quarter, Vanguard Extended Market Index Fu came rising its stake by 1.78% in the company and now holds 17194.0 or 0.09% of the company’s stake having worth of about 7995.0.
